BackTG Therapeutics Overview

TG Therapeutics Current Cash

Latest current cash for TGTX: $480M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$482.57M
273.72% YoYΔ $353.45M vs prior year quarter

Peer average / median

Loading

TG Therapeutics Current Cash History

Loading

TG Therapeutics vs. peers: Current Cash Comparison

Loading

TG Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TG Therapeutics (TGTX) FAQ

As of the most recent data (June 2026), TGTX shows a current cash of $480M. That compares with $130M in the prior-year period — up 273.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TGTX's current cash is now $480M (was $130M) — a 273.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether TG Therapeutics is outperforming or lagging.

Tracking TGTX's current cash over time shows whether TG Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $480M That compares with $130M in the prior-year period — up 273.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has TG Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $480M) with ownership activity and broader fundamentals.

TG Therapeutics's current cash is $480M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.